|
|
Drugs for Hypotrichosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 178)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Imiquimod | approved, investigational | Phase 4 | 131 | 99011-02-6 | 57469 | 1-(2-Methylpropyl)-1H-imidazole[4,5-c]quinoline-4-amine 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine 1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine 1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine 1-isobutyl-1H-imidazo(4,5-c)quinolin-4-amine 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine 3M Brand of Imiquimod 4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline 4-Amino-1-isobutyl-1H-imidazo[4,5-c]quinoline 99011-02-6 AC-529 AC1L1N2I AC1Q4YO9 Aldara Aldara (TN) Aldara, Imiquimod BB_SC-2107 BIDD:GT0859 Beselna C056493 CHEBI:36704 CHEMBL1282 CID57469 D02500 DB00724 DZ-2636 FT-0080222 HMS2090M14 I06-0624 | I06-2289 I0747 I5159_SIGMA IMIQUIMOD Imiquimod Imiquimod (JAN/USAN/INN) Imiquimod [USAN:INN] Imiquimod acetate Imiquimodum LS-178395 MLS000083577 MTD-39 MolPort-002-507-845 NCGC00070736-02 NSC369100 R 837 R-837 S 26308 S-26308 S1211_Selleck SMR000048307 STK583860 TL8006059 TMX-101 UNII-P1QW714R7M Vyloma ZINC19632912 Zartra Zyclara imiquimod | |
| | 2 | | Triamcinolone | approved | Phase 4, Phase 2 | 448 | 124-94-7 | 31307 | (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one 11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione 11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione 11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione 11beta,16alpha,17alpha,21-Tetrahydroxy-9alpha-fluoro-1,4-pregnadiene-3,20-dione 124-94-7 4-08-00-03629 (Beilstein Handbook Reference) 83474-03-7 9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9-alpha-Fluoro-16-alpha-hydroxyprednisolone 9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy 9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d 9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione 9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone 9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9alpha-Fluoro-11beta,16alpha,17alpha,21-tetrahydroxypregna-1,4-diene-3,20-dione 9alpha-Fluoro-16alpha-hydroxyprednisolone 9α-fluoro-16α-hydroxyprednisolone AC-2072 AC1L1LDH AC1Q5HJC Adcortyl Allernaze Aristocort Aristocort A Aristocort Tablets Aristogel Aristospan Azmacort BPBio1_000154 BRD-K77554836-001-03-3 BRN 2341955 BSPBio_000140 Bio-0662 C21H27FO6 CHEMBL1451 CID31307 CL 19823 Celeste Cinolone Cinolone-T D00385 D014221 DB00620 Delphicort EINECS 204-718-7 EU-0101179 Fluoxiprednisolone Fluoxyprednisolone Flutex Fougera HMS1568G22 HMS2090D12 HSDB 3194 Kenacort Kenacort (TN) Kenacort-A Kenacort-AG Kenacort-Ag Kenalog Kenalog in Orabase Kenalog-10 Kenalog-40 Kenalog-H LS-698 Ledercort Lopac0_001179 MLS000028542 MLS001066543 | MLS002695935 MolPort-002-528-981 Mycolog NCGC00021580-03 NCGC00021580-04 NCGC00021580-05 NCGC00021580-06 NCGC00021580-07 NCI60_000750 NSC 13397 NSC13397 Nasacort Nasacort Aq Nasacort Hfa Omcilon Omicilon Oracort Oralone Orion Polcortolon Pregna-1,4-diene-3,20-dio Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha) Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI) Prestwick0_000120 Prestwick1_000120 Prestwick2_000120 Prestwick3_000120 Prestwick_438 Rodinolone S1933_Selleck SK-Triamcinolone SMP1_000300 SMR000058333 SPBio_002079 Sk-Triamcinolone T6376_SIGMA TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7)) Tiamcinolonum Tiamcinolonum [INN-Latin] Tri-Nasal Triacet Triacort Triam-Tablinen Triamcet Triamcinalone Triamcinlon Triamcinolon Triamcinolona Triamcinolona [INN-Spanish] Triamcinolone (JP15/USP/INN) Triamcinolone Acetonide Triamcinolone [USAN:INN:BAN:JAN] Triamcinolone acetonide Triamcinolone diacetate Triamcinolone hexacetonide Triamcinolonum Triamcinolonum [INN] Trianex Triatex Tricortale Triderm Triesence Trilone Tristoject Trymex UNII-1ZK20VI6TY Vetalog Volon Volon A WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ ZINC03882036 droxypregna-1,4-diene-3,20-dione ione nchembio.2007.53-comp7 triamcinolone | |
| | 3 | | Methylprednisolone | approved | Phase 4 | 1082 | 83-43-2 | 6741 | (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one (6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione .DELTA.1-6.alpha.-Methylhydrocortisone 1-Dehydro-6alpha-methylhydrocortisone 1-dehydro-6alpha-Methylhydrocortisone 1-dehydro-6α-methylhydrocortisone 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 121673-01-6 4-08-00-03498 (Beilstein Handbook Reference) 46436_FLUKA 46436_RIEDEL 570-35-4 6 Methylprednisolone 6-Methylprednisolone 6-alpha-Methylprednisolone 6.alpha.-Methylprednisolone 6923-42-8 6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 6alpha-Methylprednisolone 6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 83-43-2 A-methapred AC1L1N7A Artisone-Wyeth Artisone-wyeth BPBio1_000174 BRD-K35240538-001-03-1 BRN 2340300 BSPBio_000158 Besonia Bio-0658 CHEBI:6888 CHEMBL650 CID6741 CPD000058330 D00407 D008775 DB00959 Depo-Medrol (acetate) Depo-medrol Dopomedrol EINECS 201-476-4 Esametone Firmacort HMS1568H20 HMS2090B13 HSDB 3127 LMST02030178 LS-118498 Lemod M0639_SIGMA M1665 MEPRDL MLS000028541 MLS001148159 MLS002207191 Medesone Medixon Medlone 21 | Medrate Medrol Medrol (TN) Medrol Adt Pak Medrol Dosepak Medrol adt pak Medrol dosepak Medrol, Solu-Medrol, Medrone, Methylprednisolone Medrone Mesopren Metastab Methyleneprednisolone Methylprednisolon Methylprednisolone Methylprednisolone (JP15/USP/INN) Methylprednisolone [USAN:INN:BAN:JAN] Methylprednisolone, 6-alpha Methylprednisolonum Methylprednisolonum [INN-Latin] Metilbetasone Metilprednisolona Metilprednisolona [INN-Spanish] Metilprednisolone Metilprednisolone [DCIT] Metilprednisolone [Dcit] Metipred Metrisone Metrocort Metysolon Moderin MolPort-002-528-554 NCGC00022735-03 NCI60_001657 NSC-19987 NSC19987 Nirypan Noretona Predni N Tablinen Prednol- L Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI) Prestwick0_000279 Prestwick1_000279 Prestwick2_000279 Prestwick3_000279 Prestwick_622 Promacortine Reactenol S1733_Selleck SAM002589984 SMR000058330 SPBio_002377 Sieropresol Solomet Solu-medrol Summicort Suprametil U 7532 UNII-X4W7ZR7023 Urbason Urbasone Wyacort ZINC03875560 delta(1)-6alpha-Methylhydrocortisone delta(sup 1)-6-alpha-Methylhydrocortisone methylprednisolone methylprenisolone | |
| | 4 | | Latanoprost | approved, investigational | Phase 4 | 184 | 130209-82-4 | 5282380, 5311221 | 130209-82-4 AC1NSK8Q AR-202 Ambap130209-82-4 CHEBI:6384 CHEMBL1051 CID5311221 CPD000466354 Catioprost D00356 HMS2051H11 HMS2089J17 Isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oate Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate Jsp001835 L1167_SIGMA Latanoprost Latanoprost (JAN/USAN/INN) Latanoprostum MLS000759468 MLS001424106 | MolPort-003-942-862 Nova-21027 PHXA-41 PhXA 41 PhXA34 [as 15(R,S)-isomer] PhXA41 Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate S1254_Selleck SAM001246671 SMR000466354 TL8000716 XA-41 XA41 Xalatan Xalatan (TN) Xalatan Fixed Flow Device ZINC12468792 isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinorprost-5-en-1-oate latanoprost latanoprost free acid propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate | |
| | 5 | | Hydroxychloroquine | approved | Phase 4 | 136 | 118-42-3 | 3652 | (+-)-Hydroxychloroquine (±)-hydroxychloroquine 118-42-3 2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol 2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol 2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol 2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol 2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol 5-22-10-00280 (Beilstein Handbook Reference) 7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline 7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline 7-Chloro-4-(5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl)aminoquinoline 7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline 7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline 7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline 7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline 747-36-4 (sulfate (1:1) salt) AC1L1GEW BRN 0253894 C07043 C18H26ClN3O CHEMBL1535 CID3652 D08050 DB01611 DivK1c_000942 EINECS 204-249-8 Gen-Hydroxychloroquine 200mg Tablets HCQ HMS502P04 Hidroxicloroquina Hidroxicloroquina [INN-Spanish] Hydroxychlorochin | Hydroxychloroguine Hydroxychloroquine (INN) Hydroxychloroquine Sulfate Hydroxychloroquine Sulfate (1:1) Salt Hydroxychloroquine [INN:BAN] Hydroxychloroquine sulfate Hydroxychloroquinum Hydroxychloroquinum [INN-Latin] IDI1_000942 Idrossiclorochina Idrossiclorochina [DCIT] KBio1_000942 LS-66614 MolPort-003-847-792 NCGC00159483-02 NINDS_000942 NSC4375 Oxichlorochine Oxichlorochinum Oxichloroquine Oxychlorochin Oxychloroquine PlaqueN/A Plaquenil Polirreumin Polirreumin (TN) Quensyl SPBio_001116 ST072188 Spectrum2_001238 Spectrum5_001697 UNII-4QWG6N8QKH WIN 1258 hydroxychloroquine | |
| | 6 | | Betamethasone | approved | Phase 4 | 153 | 378-44-9 | 9782 | .beta.-Methasone .beta.-Methasone alcohol 1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11 beta,17alpha,21-triol 16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione 16β-Methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione 24024-03-1 34166_FLUKA 34166_RIEDEL 378-44-9 4-08-00-03501 (Beilstein Handbook Reference) 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 9-Fluoro-16.beta.-methylprednisolone 9-Fluoro-16beta-methylprednisolone 9-Fluoro-16β-methylprednisolone 9-alpha-Fluoro-16-beta-methylprednisolone 9.alpha.-Fluoro-16.beta.-methylprednisolone 9alpha-Fluoro-16 beta-methyl-prednisolone 9alpha-Fluoro-16beta-methylprednisolone 9α-Fluoro-16β-methylprednisolone AC1L1EYE AC1L1TT4 AC1Q5HJZ AKOS001582690 AR-1A7284 AR-1H5595 B1837 B7005_SIAL B7005_SIGMA B9675_SIAL BIDD:PXR0047 BPBio1_000533 BRD-A35108200-001-04-7 BRD-K39188321-001-03-9 BRN 3176546 BSPBio_000483 Bebate Becort Bedifos Betacorlan Betacortril Betadexamethasone Betafluorene Betamamallet Betametasona Betametasona [INN-Spanish] Betametasone Betametasone [DCIT] Betamethasone Betamethasone (JP15/USP/INN) Betamethasone Base Betamethasone Dipropionate Betamethasone Valearate Betamethasone Valerate Betamethasone [USAN:BAN:INN:JAN] Betamethasone [USAN:INN:BAN:JAN] Betamethasone alcohol Betamethasone cream Betamethasone dipropionate Betamethasone sodium phosphate Betamethasone valerate Betamethasonum Betamethasonum [INN-Latin] Betamethasonvalerat Mikron Betamethazone Betapredol | Betasolon Betnelan Betsolan C22H29FO5 CHEBI:3077 CHEMBL632 CID3003 CID9782 CPD000339803 Celestene Celeston Celestona Celestone Celestone Syrup and Tablets Celestone, Betadexamethasone, Flubenisolone, Sch-4831, NCS-39470, Betamethasone Cellestoderm Cidoten D00244 D1961 DB00443 Desacort-Beta Diprolene EINECS 206-825-4 Flubenisolone HMS1569I05 HSDB 3015 Hormezon I06-0121 KST-1A3042 LS-118466 LT00441022 Luxiq Luxiqo MLS-0310139.0001 MLS000686794 MLS000859943 MLS001066413 MLS001332616 MLS002153244 Methazon MolPort-003-845-025 MolPort-007-981-051 NCGC00164401-01 NCGC00164401-02 NSC 39470 NSC-39470 NSC39470 Prestwick0_000362 Prestwick1_000362 Prestwick2_000362 Prestwick3_000362 Prestwick_703 Rinderon Rinderon (TN) Rinderon A S1500_Selleck SAM002589959 SCH 4831 SCH-4831 SMP1_000043 SMR000058601 SMR000339803 SPBio_002404 UNII-9842X06Q6M Valisone Visubeta ZINC03876136 beta-Methasone beta-Methasone alcohol betamethasone |
| | 7 | | Prednisolone | approved | Phase 4 | 1082 | 50-24-8 | 5755 | (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione .DELTA.1-Cortisol .DELTA.1-Dehydrocortisol .DELTA.1-Dehydrohydrocortisone .DELTA.1-Hydrocortisone .delta.-Cortef .delta.-Stab 1,2-Dehydrohydrocortisone 1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione 1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol 1-Dehydrocortisol 1-Dehydrohydrocortisone 3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene 46656_FLUKA 46656_RIEDEL 50-24-8 58201-11-9 8056-11-9 AC-1773 AC1L1L2E Ak-Pred Ak-Tate Alphadrol Articulose-50 BPBio1_000164 BRD-K98039984-001-03-0 BRN 1354103 BSPBio_000148 Bio-0666 Bubbli-Pred C07369 CCRIS 980 CHEBI:8378 CHEMBL131 CID5755 CO-Hydeltra CPD000718761 Co-Hydeltra Codelcortone Cordrol Cortalone Cotogesic Cotolone D00472 D011239 DB00860 Decaprednil Decortin H Delcortol Delta F Delta(1)-dehydrohydrocortisone Delta-Cortef Delta-Cortef (TN) Delta-Ef-Cortelan Delta-Stab Delta-stab Deltacortenol Deltacortril Deltacortril Enteric Deltahydrocortisone Deltasolone Deltisilone Depo-Medrol Derpo PD Derpo Pd Dexa-Cortidelt Hostacortin H Dexa-Cortidelt hostacortin H Di Adreson F Di-Adreson F Di-Adreson-F Di-adreson F DiAdresonF Dicortol Donisolone Dydeltrone EINECS 200-021-7 Eazolin D Econopred Econopred Plus Erbacort Erbasona Estilsona Fernisolone Fernisolone P Fernisolone-P Flamasone Flo-pred HMS1568H10 HMS2090J05 HSDB 3385 Hostacortin H Hydeltra Hydeltra-Tba Hydeltrasol Hydeltrone Hydrodeltalone Hydrodeltisone Hydroretrocortin Hydroretrocortine I-Pred Inflamase Forte Inflamase Mild K 1557 Key-Pred Klismacort LMST02030179 LS-7669 Lentosone Lite Pred M-Predrol MLS001304083 | MLS002154250 MLS002207037 Medrol Medrol Acetate Metacortandralone Methylprednisolone Acetate Meti-Derm Meticortelone Metreton Millipred MolPort-002-507-147 NCGC00179649-01 NSC 9120 NSC9120 NSC9900 Neo-Delta-Cortef Nisolone Nor-Pred T.B.A. Ocu-Pred Ocu-Pred Forte Omnipred Ophtho-Tate Orapred P0152_SIGMA P0637 P6004_SIGMA PRDL PRED-G Panafcortelone Paracortol Paracotol Pediapred Poly-Pred Precortalon Precortancyl Precortilon Precortisyl Pred Forte Pred Mild Predair Predair A Predair Forte Predalone 50 Predalone T.B.A. Predate Predate Tba Predate-50 Predcor-25 Predcor-50 Predcor-Tba Predisolone Sodium Phosphate Predne-Dome Prednelan Predni-Dome Prednicen Predniliderm Predniretard Prednis Prednisolona Prednisolona [INN-Spanish] Prednisolone Prednisolone (JP15/USP/INN) Prednisolone (anhydrous) Prednisolone Acetate Prednisolone Sodium Phosphate Prednisolone Tebutate Prednisolone [INN:BAN:JAN] Prednisolonum Prednisolonum [INN-Latin] Predonin Predonine Prelone Prenolone Prestwick0_000274 Prestwick1_000274 Prestwick2_000274 Prestwick3_000274 Prestwick_404 Rolisone S1737_Selleck SAM002264639 SMR000718761 SPBio_002367 Scherisolon Solone Steran Sterane Sterolone Supercortisol UNII-9PHQ9Y1OLM Ulacort Ultra Pred Ultracorten H Ultracortene H Ultracortene-H Ultracortene-Hydrogen Ultracortene-hydrogen ZINC03833821 component of Ataraxoid component of K-Predne-Dome delta(1)-Cortisol delta(1)-Dehydrocortisol delta(1)-Dehydrohydrocortisone delta(1)-Hydrocortisone delta(sup 1)-Cortisol delta(sup 1)-Dehydrocortisol delta(sup 1)-Dehydrohydrocortisone delta(sup 1)-Hydrocortisone delta-dehydrocortisol delta-dehydrohydrocortisone delta-hydrocortisone prednisolone | |
| | 8 | | Finasteride | approved | Phase 4, Phase 3, Phase 1, Phase 2 | 64 | 98319-26-7 | 57363 | (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-dimethylethyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-butyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide (5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide 17beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androst-1-en-3-one 34202_FLUKA 34202_RIEDEL 98319-26-7 AB00513901 AC1L1MUF AC1Q5L2C Andozac BPBio1_001027 BRD-K01095011-001-03-5 BRN 4269024 BSPBio_000933 C23H36N2O2 CCRIS 7438 CHEBI:5062 CHEMBL710 CID57363 CPD000466304 Cahill May Roberts Brand of Finasteride Chibro Proscar Chibro-Proscar Chibro-proscar D00321 D018120 DB01216 DB07774 Eucoprost F1293_SIGMA FIT FT-0082891 Finasterida Finasterida [INN-Spanish] Finasteride Finasteride (USP/INN) Finasteride [USAN:INN:BAN] Finasteridum Finasteridum [INN-Latin] Finastid Finpecia Frosst Iberica Brand of Finasteride HMS1570O15 | HMS2051F09 HMS2090G22 HSDB 6793 KS-1058 L-652,931 LS-7397 Lipha Brand of Finasteride MK 0906 MK 906 MK-0906 MK-906 MK906 MLS000759404 MLS001165768 MLS001424046 MSD Brand of Finasteride MSD Chibropharm Brand of Finasteride Merck Brand 1 of Finasteride Merck Brand 2 of Finasteride Merck Frosst Brand 1 of Finasteride Merck Frosst Brand 2 of Finasteride Merck Sharp & Dhome Brand 2 of Finasteride Merck Sharp & Dohme Brand 1 of Finasteride MolPort-002-500-272 N-(2-Methyl-2-propyl)-3-oxo-4-aza-5-alpha-androst-1-ene-17-beta-carboxamide N-(2-methyl-2-propyl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-en-17beta-carboxamide N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide Prestwick0_000717 Prestwick1_000717 Prestwick2_000717 Prestwick3_000717 Propecia Propecia (TN) Propeshia Proscar Proscar (TN) Proscar, Propecia, Finasteride Prostide S1197_Selleck SAM001246541 SMR000466304 SPBio_002854 UNII-57GNO57U7G YM-152 ZINC03782599 finasteride |
| | 9 | | Minoxidil | approved | Phase 4, Phase 3, Phase 1, Phase 2 | 33 | 38304-91-5 | 4201 | 16317-69-4 2,3-Dihydro-3-hydroxy-2-imino-6-(1-piperidinyl)-4-pyrimidinamine 2,4-Diamino-6-piperidinilpirimidina-3-ossido 2,4-Diamino-6-piperidinilpirimidina-3-ossido [Italian] 2,4-Diamino-6-piperidino-pyrimidine-3-oxide 2,4-Diamino-6-piperidinopyrimidine 3-N-oxide 2,4-Diamino-6-piperidinopyrimidine 3-oxide 2,4-Pyrimidinediamine, 6-(1-piperidinyl)-, 3-oxide 2,6-Diamino-4-piperidinopyrimidin-1-oxid 3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine 3-hydroxy-2-imino-6-piperidin-1-ylpyrimidin-4-amine 38304-91-5 5-25-12-00317 (Beilstein Handbook Reference) 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide 6-(piperidin-1-yl)pyrimidine-2,4-diamine 3-oxide 6-Amino-1,2-dihydro-1-hydroxy-2-imino-4-piperidinopyrimidine 6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide 6-Piperidino-2,4-diaminopyrimidine 3-oxide 6-[1-Piperidinyl]pyrimidine-2,4-diamine 3 oxide AB00513797 AC-5271 AC1L1HN1 Alopexil Alostil Ambap38304-91-5 Apo-Gain Apo-gain BCBcMAP01_000193 BPBio1_000065 BRD-K06902185-001-05-2 BRD-K14888893-001-02-3 BRN 0886240 BSPBio_000059 BSPBio_001385 BSPBio_002037 Bio1_000084 Bio1_000573 Bio1_001062 Bio2_000105 Bio2_000585 Boost Regrowth For Women Bosley Professional Strength Hair Regrowth Treatment Regular Strength For Men Bosley Professional Strength Hair Regrowth Treatment Regular Strength For Women C9H15N5.H2O CAS-38304-91-5 CBiol_001798 CHEBI:49774 CHEBI:6942 CHEMBL609587 CHEMBL802 CID4201 CPD-7668 CPD000058963 Careone Hair Regrowth Treatment Careone Hair Regrowth Treatment Extra Strength Cerafill Retaliate Cerafill Retaliate Extra Strength For Men D00418 D008914 DB00350 DB08225 DivK1c_000160 EINECS 253-874-2 EU-0100786 Equaline Hair Regrowth Treatment For Men Equaline Hair Regrowth Treatment For Women Equaline Hair Regrowth Treatment for men Equaline Hair Regrowth Treatment for women Equate Hair Regrowth Treatment Equate Hair Regrowth Treatment for men Equate Hair Regrowth Treatment for women Gen-Minoxidil Good Neighbor Pharmacy Hair Regrowth Treatment For Men Good Sense Hair Regrowth Treatment Good Sense Hair Regrowth Treatment for Men Good Sense Hair Regrowth Treatment for women HMS1361F07 HMS1568C21 HMS1791F07 HMS1920P03 HMS1989F07 HMS2089L08 HMS2091F20 HMS500H22 HSDB 6538 Hair Regrowth Treatment Hair Regrowth Treatment Extra Strength for Men Hair Regrowth Treatment For Men Hair Regrowth Treatment For Men Extra Strength Hair Regrowth Treatment For Women Hair Regrowth Treatment for women Hair Regrowth treatment for men Hair Regrowth treatment for women Harmon Face Values Minoxidil IDI1_000160 IDI1_033855 Image Essentials Hair Regrowth Treatment Image Essentials Hair Regrowth Treatment For Men Jsp006715 KBio1_000160 KBio2_000105 KBio2_001449 KBio2_002673 KBio2_004017 KBio2_005241 KBio2_006585 KBio3_000209 KBio3_000210 KBio3_001537 KBioGR_000105 KBioGR_000585 KBioSS_000105 KBioSS_001449 Keranique For Women Hair Regrowth Treatment Kirkland Signature Minoxidil LS-135040 Leader Hair Regrowth Treatment Loesch Hair Regrowth Formula Unscented Topical Solution Extra-Strength for Men | Loniten Loniten (TN) Lonolox Lopac-M-4145 Lopac0_000786 M 4145 M1389 MINOXIDIL (FOR MEN) MINOXIDIL (FOR WOMEN) MINOXIDIL EXTRA STRENGTH (FOR MEN) MINOXIDIL EXTRA STRENGTH FOR MEN MLS000028566 MLS000859953 MLS001077294 Men s Rogaine Foam Men's Rogaine Mens Comback Hair Regrowth Treatment Extra Strength Unscented Mens Hair Regrowth Treatment extra strength Mens Kirkland Extra Strength Mens Rogaine Extra Strength Mens Rogaine Foam Mens Rogaine Unscented Formula Minodyl Minossidile Minossidile [Italian] Minoxidil Minoxidil (USP/INN) Minoxidil Foam Minoxidil For Women Minoxidil Form Men extra strength Minoxidil Pfizer Brand Minoxidil [USAN:BAN:INN] Minoxidil for men Minoxidil for women Minoxidil regular strength Minoxidilum Minoxidilum [INN-Latin] Minoxigaine Minoximen MolPort-003-666-236 MolPort-005-932-694 NCGC00015673-01 NCGC00015673-02 NCGC00015673-04 NCGC00015673-11 NCGC00018278-01 NCGC00024666-01 NCGC00024666-02 NCGC00024666-03 NCGC00024666-04 NCGC00024666-05 NCGC00024666-06 NCGC00024666-07 NCGC00024666-08 NCGC00179672-01 NINDS_000160 Neoxidil Nioxin Hair Regrowth Treatment Extra Strength For Men Nioxin Hair Regrowth Treatment For Women Normoxidil Pantene Pro-v Expert Collection Hair Regrowth Treatment for Women Pfizer Brand of Minoxidil Pierminox Prestwick0_000020 Prestwick1_000020 Prestwick2_000020 Prestwick3_000020 Prestwick_521 Prexidil Pyrimidine, 2,4-diamino-6-piperidino-, 3-oxide ROGAINE (FOR MEN) ROGAINE (FOR WOMEN) ROGAINE EXTRA STRENGTH (FOR MEN) Re-gro Regaine Renewal For Men RiUP Riup (TN) Rogaine Rogaine (TN) Rogaine Extra Strength for Men Rogaine for Men Rogaine for Women Rogaine, Regaine, Avacor and Mintop, Minoxidil S1383_Selleck SAM002589949 SBB056986 SGCUT00112 SMP1_000192 SMR000058963 SMR000326812 SPBio_001006 SPBio_001980 SPECTRUM1500415 Simply Right Minoxidil Simply Right Minoxidil extra strength Solution Spectrum2_001053 Spectrum3_000509 Spectrum4_000063 Spectrum5_001299 Spectrum_000969 TM-160 Theroxidil Tocris-0583 Toppik Mens Hair Regrowth Treatment Extra Strength Toppik Womens Hair Regrowth Treatment Tricoxidil Trocoxidil U 10858 U-10,858 U-10858 Vanarex Hair Regrowth Treatment Womens Rogaine - Unscented Womens Rogaine Unscented ZINC00001735 minoxidil nchembio.79-comp10 to_000070 | |
| | 10 | | Bimatoprost | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 129 | 155206-00-1 | 5311027 | (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide (Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide (Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide 155206-00-1 15M 267244-98-4 5-Heptenamide,7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ehtyl-,(5Z) AC1NSJUW AGN 192024 AGN-192024 Bimataprost [USAN:INN:BAN] Bimatoprost Bimatoprost (JAN/USAN/INN) Bimatoprost [USAN:INN:BAN] Bimatoprostum | CHEBI:39562 CHEBI:51230 CHEMBL1200963 CID5311027 D02724 DB00905 DB06863 I06-1275 I06-1277 LS-181817 Latisse Lumigan Lumigan (TN) NCGC00181745-01 UNII-QXS94885MZ ZINC04474405 bimatoprostum | |
| | 11 | | Spironolactone | approved | Phase 4, Phase 2 | 159 | 1952-01-7, 52-01-7 | 5833 | 4-18-00-01601 (Beilstein Handbook Reference) 4-Pregnen-21-oic acid-17alpha-ol-3-one-7alpha-thiol gamma-lactone 7-acetate 496916-40-6 52-01-7 7-alpha-Acetylthio-3-oxo-17-alpha-pregn-4-ene-21,17-beta-carbolactone 7alpha-(acetylsulfanyl)-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone AB00513806 AC-4214 AC1L1L8Q Abbolactone Acelat Aldace Aldactazide Aldactide Aldactone Aldactone (TN) Aldactone A Alderon Aldopur Almatol Alphapharm Brand of Spironolactone Alpharma Brand of Spironolactone Alter Brand of Spironolactone Altex Aquareduct Ashbourne Brand of Spironolactone Azupharma Brand of Spironolactone BIDD:PXR0071 BPBio1_000194 BRD-K90027355-001-03-4 BRN 0057767 BSPBio_000176 C07310 C24H32O4S CHEBI:428201 CHEBI:45692 CHEBI:9241 CHEMBL1393 CID5833 CPD000471892 Cardel Brand of Spironolactone D00443 D013148 DB00421 Deverol Dexo Brand of Spironolactone Diatensec Dira Duraspiron EINECS 200-133-6 Espironolactona Espironolactona Alter Espironolactona Mundogen Espironolactona [INN-Spanish] Euteberol Flumach Frumikal Generosan Brand of Spironolactone HMS1568I18 HMS2090N21 HSDB 3184 Hormosan Brand of Spironolactone I06-1970 Jenapharm Brand of Spironolactone Jenaspiron LS-118614 LT00772287 Lacalmin Lacdene Laractone MLS001074672 MLS001333253 MLS001333254 MLS002153245 MLS002207058 Mayoly-Spindler Brand of Spironolactone Melarcon Merck dura Brand of Spironolactone Mundogen Brand of Spironolactone NCGC00164397-01 | NCGC00164397-02 NSC 150399 NSC150399 Nefurofan Novo Spiroton Novo-Spiroton NovoSpiroton Novopharm Brand of Spironolactone Osyrol Pfizer Brand of Spironolactone Pharmafrid Brand of Spironolactone Practon Prestwick0_000128 Prestwick1_000128 Prestwick2_000128 Prestwick3_000128 Roche Brand of Spironolactone S0260 S3378_SIGMA SAM002264648 SC 9420 SC-9420 SC9420 SMR000471892 SNL SPBio_002115 Sagisal Searle Brand of Spironolactone Sincomen Spiractin Spiresis Spiretic Spiridon Spiro L.U.T. Spiro(17H-cyclopenta(a)phenauthrene-17,2'-(3'H)-furan) Spiro-Tablinen Spiro[17H-cyclopenta[a]phenauthrene-17,2'-(3'H)-furan] Spirobeta Spiroctan Spiroctanie Spiroderm Spirogamma Spirolactone Spirolakton Spirolang Spirolone Spirone Spirono Isis Spirono-Isis Spironocompren Spironolactone Spironolactone (JP15/USP/INN) Spironolactone A Spironolactone [BAN:INN:JAN] Spironolactone [INN:BAN:JAN] Spironolactonum Spironolactonum [INN-Latin] Spironolattone Spironolattone [DCIT] Spironone Spirospare Sprioderm Supra-puren Suracton UNII-27O7W4T232 Uractone Urusonin Veroshpiron Verospiron Verospirone Verospirone Opianin WLN: L E5 B666 FX OV MUTJ A1 E1 KSV1 F-& CT5VOXTJ Worwag Brand of Spironolactone Xenalon ZINC03861599 betapharm Brand of Spironolactone ct Arzneimittel Brand of Spironolactone ct-Arzneimittel Brand of Spironolactone spiro von ct spironolactone spironolattone von ct, spiro |
| | 12 | | Antiprotozoal Agents | | Phase 4 | 1730 | | | | 13 | | Antirheumatic Agents | | Phase 4, Phase 3, Phase 2 | 8496 | | | | 14 | | Antiparasitic Agents | | Phase 4 | 1854 | | | | 15 | | Antimalarials | | Phase 4 | 1058 | | | | 16 | | Protective Agents | | Phase 4, Phase 2, Phase 3, Phase 1 | 5651 | | | | 17 | | Anti-Infective Agents | | Phase 4, Phase 2 | 17220 | | | | 18 | | Prednisolone phosphate | | Phase 4 | 1082 | | | | 19 | | Dermatologic Agents | | Phase 4, Phase 3 | 4555 | | | | 20 | | Triamcinolone hexacetonide | | Phase 4, Phase 2 | 448 | | | | 21 | | Clobetasol | | Phase 4, Phase 3 | 70 | 25122-46-7 | 32798, 5311051 | (11beta,16beta)-21-chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione (8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one (9R,17R)-17-(2-chloroacetyl)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one 17-(2-chloroacetyl)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one 21-Chloro-9-fluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 21-chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione 25122-41-2 AC-1775 AC1L1OG6 AC1NDRJ9 AC1NSJWK BB_NC-1906 C22H28ClFO4 CHEBI:205919 CHEMBL1201362 CID10341542 CID32797 | CID4630419 CID5311051 CID9844480 Clobecort Amex Clobecort Amex (TN) Clobetasol (INN) Clobetasol [INN:BAN] Clobetasolum Clobetasolum [INN-Latin] Clofenazon D07715 EINECS 246-633-8 LS-174086 MolPort-005-909-335 NCGC00164580-01 STK801976 UNII-ADN79D536H ZINC26892643 clobetasol |
| | 22 | | 5-alpha Reductase Inhibitors | | Phase 4, Phase 3, Phase 1, Phase 2 | 155 | | | | 23 | | Antihypertensive Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 3618 | | | | 24 | | Triamcinolone diacetate | | Phase 4, Phase 2 | 448 | | | | 25 | | triamcinolone acetonide | | Phase 4, Phase 2 | 448 | | | | 26 | | Capsaicin | | Phase 4 | 144 | 404-86-4 | 1548943 | (6E)-N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide (6E)-N-{[4-hydroxy-3-(methyloxy)phenyl]methyl}-8-methylnon-6-enamide (E)-8-Methyl-N-vanillyl-6-nonenamide (E)-8-Methyl-N-vanillyl-6-nonenamide(8cl) (E)-Capsaicin (E)-N-((4-Hydroxy-3-methoxyphenyl)-methyl)-8-methyl-6-nonenamide (E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide (E)8-methyl-N-vanillyl-6-Nonenamide 12084_FLUKA 21748_FLUKA 21748_SIGMA 21750_FLUKA 21750_SIGMA 360376_ALDRICH 360376_SIGMA 404-86-4 6-Nonenamide, (E)-N-((4-hydroxy-3-methoxy-phenyl)methyl)-8-methyl 6-Nonenamide, 8-methyl-N-vanillyl-, (E)- (8CI) 8 Methyl N Vanillyl 6 Nonenamide 8-Methyl-N-Vanillyl-6-Nonenamide 8-Methyl-N-vanillyl-trans-6-nonenamide 912457-62-6 AC1LU7K3 AC1Q46B3 Alacan Brand of Capsaicin Antiphlogistine Rub A-535 Capsaicin Axsain BPBio1_001053 BRD-K37056290-001-01-1 BRD-K50590187-001-06-6 BRN 2816484 BSPBio_000957 BSPBio_001548 BSPBio_002917 Bio-0615 C-1700 C06866 C18H27NO3 CAPSAICIN (2444-46-4 NONIVAMIDE (SYNTHETIC CAPSAICIN)) CAPSAICINE CCRIS 1588 CHEBI:3374 CHEMBL294199 CID1548943 Capsaicin Capsaicin (JAN/USP) Capsaicin (Natural) Capsaicin (in oleoresin of capsicum) Capsaicin (jan/usp) Capsaicin Patch Capsaicin [USAN] Capsaicin [in oleoresin of capsicum] Capsaicin [usan] Capsicum Farmaya Capsidol Capsin Capzasin Carter Horner Brand of Capsaicin Caswell No. 158 Centrum Brand of Capsaicin D002211 D00250 E-CAPSAICIN E-Capsaicin EINECS 206-969-8 EPA Pesticide Chemical Code 070701 Elan Brand of Capsaicin FEMA No. 3404 FT-0082538 Flemming Brand of Capsaicin Gelcen HMS1361N10 HMS1570P19 HMS1791N10 HMS1921H11 HMS1989N10 | HMS2089N11 HMS2092D21 HMS501B16 HSDB 954 I01-2469 IDI1_000354 IDI1_034018 Isodecenoate Isodecenoic acid Isodecenoic acid vanillylamide Katrum LS-2138 Link Brand of Capsaicin M1149 M2028_SIGMA MEGxp0_001448 MLS002154049 MR3H3 Medicis Brand of Capsaicin MolPort-001-742-263 N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide N-[(4-hydroxy-3-methoxy-phenyl)methyl]nonanamide NCGC00090853-01 NCGC00090853-02 NCGC00090853-03 NCGC00090853-04 NCGC00090853-06 NCGC00090853-07 NCGC00090853-08 NCGC00090853-09 NCI-C56564 NGX 4010 NGX-1998 NGX-3781 NGX-4010 NGX-7325 NGX4010 NSC 56353 NSC56353 Prestwick2_000879 Prestwick3_000879 Prestwick_204 Qutenza S1990_Selleck SDCCGMLS-0066678.P001 SMP2_000337 SMR000718774 SPECTRUM1501128 Smaller Brand of Capsaicin Spectrum5_000538 Styptysat TL8002946 TQ-1018 Thompson Brand of Capsaicin Transacin UNII-S07O44R1ZM UPCMLD-DP092 UPCMLD-DP092:001 UPCMLD-DP092:002 Vinas Brand of Capsaicin ZINC01530575 ZOSTRIX (TN) Zacin Zostrix Zostrix (TN) Zostrix HP [(E)-N-(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide depletes Substance P epsilon-Capsaicin n-(4-hydroxy-3-methoxybenzyl)-8-methyl-6-nonenamide nchembio.146-comp1 nchembio862-comp2 neurotoxic trans-8-Methyl-N-vanillyl-6-nonenamide trans-Capsaicin | |
| | 27 | | Prednisolone hemisuccinate | | Phase 4 | 1082 | | | | 28 | | Immunologic Factors | | Phase 4, Phase 3, Phase 2 | 18483 | | | | 29 | | Antipruritics | | Phase 4 | 619 | | | | 30 | | Immunosuppressive Agents | | Phase 4, Phase 3, Phase 2 | 10422 | | | | 31 | | Betamethasone Valerate | | Phase 4 | 153 | 2152-44-5 | | | 32 | | Betamethasone-17,21-dipropionate | | Phase 4 | 153 | | | | 33 | | Ophthalmic Solutions | | Phase 4, Phase 2 | 1006 | | | | 34 | | glucocorticoids | | Phase 4, Phase 3, Phase 2 | 3896 | | | | 35 | | Betamethasone sodium phosphate | | Phase 4 | 153 | | | | 36 | | Betamethasone benzoate | | Phase 4 | 153 | | | | 37 | | Vasodilator Agents | | Phase 4, Phase 3, Phase 1, Phase 2 | 2926 | | | | 38 | | Anti-Asthmatic Agents | | Phase 4, Phase 1, Phase 2 | 2796 | | | | 39 | | Prednisolone acetate | | Phase 4 | 1082 | | | | 40 | | Anti-Inflammatory Agents | | Phase 4, Phase 3, Phase 2 | 8478 | | | | 41 | | Hormones | | Phase 4, Phase 3, Phase 2, Phase 1 | 11748 | | | | 42 | | Hormone Antagonists | | Phase 4, Phase 3, Phase 2, Phase 1 | 10002 | | | | 43 | | Methylprednisolone Hemisuccinate | | Phase 4 | 1082 | | | | 44 | | Neuroprotective Agents | | Phase 4, Phase 2 | 1376 | | | | 45 | | Pharmaceutical Solutions | | Phase 4, Phase 3, Phase 2, Phase 1 | 7004 | | | | 46 | | Peripheral Nervous System Agents | | Phase 4, Phase 2, Phase 3, Phase 1 | 18510 | | | | 47 | | Gastrointestinal Agents | | Phase 4 | 6401 | | | | 48 | | Methylprednisolone acetate | | Phase 4 | 1082 | | | | 49 | | Hormones, Hormone Substitutes, and Hormone Antagonists | | Phase 4, Phase 3, Phase 2, Phase 1 | 9988 | | | | 50 | | Antiemetics | | Phase 4 | 3213 | | |
Interventional clinical trials: (show top 50)
(show all 174)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo | Completed | NCT01387906 | Phase 4 | | 2 | Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows | Completed | NCT01891487 | Phase 4 | | 3 | Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis | Completed | NCT00958035 | Phase 4 | | 4 | Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children | Completed | NCT01023841 | Phase 4 | | 5 | Minoxidil 2% for Eyebrow Enhancement | Completed | NCT01672307 | Phase 4 | | 6 | Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence | Completed | NCT01448525 | Phase 4 | | 7 | Minoxidil 1% for Eyebrow Enhancement | Completed | NCT01924000 | Phase 4 | | 8 | Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects | Completed | NCT01229423 | Phase 4 | | 9 | Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata | Completed | NCT02350023 | Phase 4 | | 10 | Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata | Completed | NCT01167946 | Phase 4 | | 11 | Aldara for the Treatment of Extensive Alopecia Areata | Completed | NCT00177021 | Phase 4 | | 12 | Plaquenil for Alopecia Areata, Alopecia Totalis | Completed | NCT00176982 | Phase 4 | | 13 | Response of Topical Capsaicin in Alopecia Areata | Completed | NCT00176969 | Phase 4 | | 14 | Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5% | Completed | NCT00176943 | Phase 4 | | 15 | Intralesional Steroids in the Treatment of Alopecia Areata | Recruiting | NCT01898806 | Phase 4 | | 16 | Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia | Recruiting | NCT01111981 | Phase 4 | | 17 | Acupuncture for Sedation in the Intensive Care Unit (ICU) | Active, not recruiting | NCT01362270 | Phase 4 | | 18 | The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia | Not yet recruiting | NCT02483195 | Phase 4 | | 19 | Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis | Completed | NCT01391273 | Phase 3 | | 20 | Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis | Completed | NCT01391286 | Phase 3 | | 21 | Bimatoprost for the Treatment of Eyebrow Hypotrichosis | Completed | NCT01765764 | Phase 3 | | 22 | Bimatoprost in the Treatment of Eyelash Hypotrichosis | Completed | NCT01698554 | Phase 3 | | 23 | Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin | Completed | NCT00907426 | Phase 3 | | 24 | Study of Bimatoprost Gel on Eyelash Growth | Completed | NCT01200251 | Phase 3 | | 25 | A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia | Completed | NCT01831791 | Phase 3 | | 26 | Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM) | Completed | NCT01590238 | Phase 3 | | 27 | A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata | Completed | NCT01453686 | Phase 3 | | 28 | Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss | Completed | NCT01391156 | Phase 3 | | 29 | Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia | Completed | NCT01231607 | Phase 3 | | 30 | Clinical Trial in Females for Female Pattern Hair Loss | Completed | NCT01226459 | Phase 3 | | 31 | Clinical Trial in Females With Female Pattern Hair Loss | Completed | NCT01145625 | Phase 3 | | 32 | The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis | Completed | NCT00997815 | Phase 2, Phase 3 | | 33 | Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia | Completed | NCT00958750 | Phase 3 | | 34 | A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia | Completed | NCT00441116 | Phase 3 | | 35 | Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111) | Completed | NCT00396175 | Phase 3 | | 36 | A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss | Completed | NCT00151515 | Phase 3 | | 37 | Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata | Completed | NCT00063076 | Phase 2, Phase 3 | | 38 | Topical Garlic Concentrate for Alopecia Areata in Children | Recruiting | NCT02691117 | Phase 3 | | 39 | TREg Activation in the Treatment of the PELADE (Alopecia Areata) | Recruiting | NCT02557074 | Phase 3 | | 40 | The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade | Recruiting | NCT02037191 | Phase 3 | | 41 | Scalp Cooling to Prevent Chemo-induced Hair Loss | Recruiting | NCT01986140 | Phase 3 | | 42 | The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia | Active, not recruiting | NCT02594046 | Phase 3 | | 43 | Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia | Active, not recruiting | NCT02014584 | Phase 3 | | 44 | Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients | Active, not recruiting | NCT01655108 | Phase 3 | | 45 | Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence | Completed | NCT01064882 | Phase 2 | | 46 | Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application | Completed | NCT02280603 | Phase 1, Phase 2 | | 47 | A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA) | Completed | NCT02275351 | Phase 2 | | 48 | Topical Bimatoprost Effect on Androgen Dependent Hair Follicles | Completed | NCT02170662 | Phase 2 | | 49 | Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata | Completed | NCT01950780 | Phase 2 | | 50 | A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA) | Completed | NCT01904721 | Phase 2 |
Cochrane evidence based reviews: hypotrichosis
|
